Efficacy and safety of indacaterol 150 <it>μ</it>g once-daily in COPD: a double-blind, randomised, 12-week study
<p>Abstract</p> <p>Background</p> <p>Indacaterol is a novel, once-daily (o.d.) inhaled, long-acting <it>β</it><sub>2</sub>-agonist in development for chronic obstructive pulmonary disease (COPD). This 12-week, double-blind study compared the effi...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-03-01
|
| Series: | BMC Pulmonary Medicine |
| Online Access: | http://www.biomedcentral.com/1471-2466/10/11 |